Home

Latest News

12345678910
Tesla Price Target Hiked By Goldman Sachs Despite Q2 Delivery Drop: Analysts Point To ‘Meaningfully Better’ Numbersstocktwits.com
Goldman Sachs’ new price target represents a 0.2% downside from TSLA’s closing price on Wednesday.
Via Stocktwits · July 3, 2025
This Tech Giant Now Claims Artificial Intelligence Is Doing Up to 50% of Its Workfool.com
Via The Motley Fool · July 3, 2025
USD/JPY Forecast: Dollar Rebounds After US-Vietnam Trade Dealtalkmarkets.com
The USD/JPY forecast shows a rebound as the dollar gains on trade optimism.
Via Talk Markets · July 3, 2025
Cadence, Synopsys Jump After China Export Curbs Liftedinvestors.com
Cadence and Synopsys rose Thursday after the U.S. lifted export restrictions on electronic design automation tools to China.
Via Investor's Business Daily · July 3, 2025
This PNC Financial Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursdaybenzinga.com
Via Benzinga · July 3, 2025
Beating The Oddstalkmarkets.com
In an outcome that most would not have predicted over the last several days and weeks, the House is likely to pass the Reconciliation Bill ahead of the July 4th holiday.
Via Talk Markets · July 3, 2025
Gold Edges Lower With All Eyes On The US NFP Reportcontent/com
Gold price edges lower ahead of the US Nonfarm Payrolls data.
Via Talk Markets · July 3, 2025
This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursdaybenzinga.com
Via Benzinga · July 3, 2025
Markets Brace For Jobs Report Ahead Of Holiday Weekendtalkmarkets.com
The dollar remains steady ahead of today’s key U.S. non-farm payrolls report, with expectations centered around 106k.
Via Talk Markets · July 3, 2025
Apple’s China iPhone Sales Rebound In Q2, Ending 2-Year Slumpstocktwits.com
Apple’s iPhone sales in China rose 8% in Q2, marking their first increase in two years, aided by promotions and trade-in deals, according to Counterpoint Research.
Via Stocktwits · July 3, 2025
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myelomabenzinga.com
FDA grants accelerated approval to Regeneron's Lynozyfic for relapsed multiple myeloma after strong results in a Phase 1/2 trial.
Via Benzinga · July 3, 2025
Quant Says Middleware Will Rule the Stackstocktwits.com
Experts agree legacy rails will merge with tokenized systems, demanding interoperability, reversibility, and balanced regulation.
Via Stocktwits · July 3, 2025
Peering Into Microsoft's Recent Short Interestbenzinga.com
Via Benzinga · July 3, 2025
This Meta Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Thursdaybenzinga.com
Via Benzinga · July 3, 2025
Why CoreWeave Rallied 46.5% in Junefool.com
Via The Motley Fool · July 3, 2025
Krispy Kreme Names Insider Raphael Duvivier As New CFO A Week After Ending McDonald’s Partnershipstocktwits.com
Krispy Kreme on Thursday named Raphael Duvivier as its new CFO, succeeding Jeremiah Ashukian, who is leaving the company to pursue an opportunity with a private company.
Via Stocktwits · July 3, 2025
Elon Musk's Dad Supports Trump's Bill, Advises Musk-Trump To 'Talk It Out': 'United States Needs Lot Of Rebuilding...They Need To Spend Money'benzinga.com
Errol Musk, father of Elon Musk, voiced his opinion over the escalating tension between his son and President Donald Trump. The senior Musk also offered advice to both parties.
Via Benzinga · July 3, 2025
The TSLY ETF Is an Income Monsterfool.com
Via The Motley Fool · July 3, 2025
DXY: US Dollar Index Forecast Ahead Of High Stakes NFP Datatalkmarkets.com
The US Dollar Index crashed this week, reaching its lowest level since February 2022, as traders waited for the upcoming US nonfarm payrolls data
Via Talk Markets · July 3, 2025
Bitcoin, Ethereum Poised For Bullish July, Experts Say, But Only One Is 'Underowned'benzinga.com
Crypto markets could see a shift this July, but analysts emphasize that Bitcoin's (CRYPTO: BTC) movement around the $110,000 mark will determine whether the market breaks hig
Via Benzinga · July 3, 2025
Honeywell, Caterpillar, Freeport-McMoRan And A Health Care Stock On CNBC's 'Final Trades'benzinga.com
Wall Street optimistic for July 4 weekend, sees opportunities in Freeport-McMoRan, Honeywell, Caterpillar, and Amgen. Analysts raise targets.
Via Benzinga · July 3, 2025
Leading And Lagging Sectors For July 3, 2025benzinga.com
Via Benzinga · July 3, 2025
BTC/USD Forex Signal: Bitcoin Targets $115,000 After Breaking Outtalkmarkets.com
Bitcoin surged past $110K after a bullish breakout and weak ADP jobs data, with bulls eyeing the $115K target ahead of Friday’s key NFP report.
Via Talk Markets · July 3, 2025
Don't Bury The US Labor Market Just Yet: June Jobs Report Beats Every Forecastbenzinga.com
U.S. nonfarm payrolls surged by 147,000 in June, beating expectations and easing recession fears. The dollar jumped, but gold dropped.
Via Benzinga · July 3, 2025
This Dan Ives-Backed ETF Could Be the Smartest Way to Play the AI Revolutionfool.com
What sets the Dan Ives AI Revolution ETF apart from other tech funds? Here's what you need to know.
Via The Motley Fool · July 3, 2025
Beyond The Numbers: 7 Analysts Discuss Credo Technology Group Stockbenzinga.com
Via Benzinga · July 3, 2025
What 33 Analyst Ratings Have To Say About NVIDIAbenzinga.com
Via Benzinga · July 3, 2025
Analyst Expectations For ONEOK's Futurebenzinga.com
Via Benzinga · July 3, 2025
The Analyst Verdict: Advance Auto Parts In The Eyes Of 15 Expertsbenzinga.com
Via Benzinga · July 3, 2025
Stocks making big moves yesterday: Tesla, Reddit, Coinbase, Oscar Health, and Intel
Check out the companies making headlines yesterday:
Via StockStory · July 3, 2025
Deep Dive Into Intel Stock: Analyst Perspectives (14 Ratings)benzinga.com
Via Benzinga · July 3, 2025
What's Driving the Market Sentiment Around Vertiv Holdings?benzinga.com
Via Benzinga · July 3, 2025
Looking Into Republic Services's Recent Short Interestbenzinga.com
Via Benzinga · July 3, 2025
Assessing Broadcom: Insights From 25 Financial Analystsbenzinga.com
Via Benzinga · July 3, 2025
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullishstocktwits.com
Giant cell arteritis (GCA) is the most common form of systemic vasculitis, a group of rare autoimmune diseases characterized by inflammation of blood vessels.
Via Stocktwits · July 3, 2025
Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trialbenzinga.com
Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial data.
Via Benzinga · July 3, 2025
Prediction: This Artificial Intelligence (AI) Stock Could Outpace Nvidia After the Next Chip Upgradefool.com
Via The Motley Fool · July 3, 2025
Elliott Wave Technical Analysis MARA Holdings Inc.talkmarkets.com
The stock is testing the upper boundary of a parallel channel, indicating a possible short-term peak.
Via Talk Markets · July 3, 2025
Telegram's Rumored IPO: What Investors Should Knowbenzinga.com
The buzz around Telegram's potential initial public offering (IPO) has intensified since the company rolled out $1.7 billion in eurobonds.
Via Benzinga · July 3, 2025
Arthur Hayes Shares His 'Stablecoin Play' — And It Isn't Betting On Circlebenzinga.com
Arthur Hayes has laid out a detailed case for why the U.S.
Via Benzinga · July 3, 2025
Why Is Alphabet Stock Worth Less Than Nvidia, Microsoft, Apple, and Amazon Even Though It Is the Most Profitable S&P 500 Company?fool.com
Via The Motley Fool · July 3, 2025
INTREPID POTASH INC (NYSE:IPI) – A Strong Contender in Growth and Momentum Investingchartmill.com
INTREPID POTASH INC (NYSE:IPI) meets Minervini’s Trend Template with strong technicals and high growth momentum, supported by earnings and revenue expansion. A breakout above $38.19 could signal further upside.
Via Chartmill · July 3, 2025
Gold Declines As Trade Optimism Reduces Safe-Haven Demand, While A Weak Dollar Limits Lossescontent/com
On Thursday, the price of gold fell to 3,340 USD per troy ounce, partially correcting the previous day’s gains.
Via Talk Markets · July 3, 2025
Cramer Doesn't Recommend Titan International, Joby Aviation Soars After Milestone Flightbenzinga.com
Cramer said with Titan International just moving up "so huge," he can't recommend the stock following that big move.
Via Benzinga · July 3, 2025
These Fossil Fuels Stocks Rallied As Senate Passed Trump's Tax, Spending Planinvestors.com
Fossil fuel-related stocks in the coal and oil drilling sectors soared in Wednesday's stock market.
Via Investor's Business Daily · July 3, 2025
LOWE'S COS INC (NYSE:LOW) - A Reliable Dividend Stock Worth Consideringchartmill.com
LOWE'S COS INC (NYSE:LOW) offers a reliable dividend with strong growth, solid profitability, and reasonable valuation, making it a candidate for dividend investors.
Via Chartmill · July 3, 2025
Gold Struggles For Momentum Amid Dovish Fed Signals And Trade Reliefcontent/com
Gold stays range-bound as dovish Fed signals and easing trade tensions support prices, while stronger risk appetite and weak US labor data cap gains.
Via Talk Markets · July 3, 2025
Top 3 Financial Stocks You May Want To Dump This Quarterbenzinga.com
Via Benzinga · July 3, 2025
Starbucks Offers $6 Million Stock Bonus To Execs — But Should You Buy Its Shares? Here's What Technical Analysis Showsbenzinga.com
Starbucks has announced giving its executives stock grants with a $6 million target value each if they deliver on the company's turnaround.
Via Benzinga · July 3, 2025
June Jobs Report Shows US Labor Market Resilient Amid Tariff, Rate Cut Uncertaintystocktwits.com
The total nonfarm payroll employment increased by 147,000 in June, more than the expected increase of 110,000, according to economists’ estimates.
Via Stocktwits · July 3, 2025